Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 281300 of 20,252 grants

Active NON-SBIR/STTR RPGS
Development of Protein Degraders Targeting EZH2 Non-enzymatic Functions in Prostate Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

Summary Prostate cancer (PCa) is the most commonly diagnosed non-skin cancer in American men. A majority of localized PCa can be effectively managed by radiation and surgery, with...

$6.64M
USD
Active NON-SBIR/STTR RPGS
Investigating epigenetic mechanisms of cancer
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2029

Project Summary Disruptions of epigenetic mechanisms that regulate gene expression are frequently found in cancer and collaborate with genetic alterations to drive cancer phenotype...

$1.62M
USD
Active TRAINING, INSTITUTIONAL
ADVANCE Cancer Health Disparities Research (CHDR) Training Program
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2029

ABSTRACT The ADVANCE Cancer Health Disparities Research (CHDR) Training Program at the University of Southern California (USC) is based on a strong foundation of biomedical researc...

$2.22M
USD
Active NON-SBIR/STTR RPGS
The next generation of liquid biopsies: Predictive and pharmacologic biomarkers
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

Project Summary: The laboratory of Dr. Joshua Lang is focused on targeting treatment resistant PCa through developing new biomarkers for precision medical strategies using liquid b...

$1.04M
USD
Active NON-SBIR/STTR RPGS
Development and Deployment of Liquid Biopsies in Bench Research and Clinical Trials in the UW Circulating Biomarker Core
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2024 – 2029

Minimally invasive liquid biopsies have revolutionized our understanding of cancer biology and emerged as biomarkers for disease monitoring and drug development, but have been limi...

$927.8K
USD
Active NON-SBIR/STTR RPGS
Exosome Secretion in Tumor Aggressiveness
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2029

PROJECT SUMMARY Exosomes are a type of small extracellular vesicle (EV) secreted from all kinds of cells, derived from endosomes. They have many physiological and pathological func...

$2.01M
USD
Active NON-SBIR/STTR RPGS
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

PROJECT SUMMARY Although immune checkpoint blockade (ICB) has become a standard cancer therapy, most patients – including ~70% of those with non-small cell lung cancer (NSCLC) – fa...

$6.41M
USD
Active NON-SBIR/STTR RPGS
Analytic diagnosis methods for disease ruling
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Disease ruling, that is, ruling-out or ruling-in, is a main objective of cancer diagnosis to aid in medical decision making. Taking prostate cancer as our...

$3.46M
USD
Active NON-SBIR/STTR RPGS
Developmental transcription factors in Drosha-driven cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Pineoblastoma is one of a family of childhood cancers that can arise through mutations in microRNA processing genes DROSHA and DICER1. It is unknown whethe...

$4.47M
USD
Active NON-SBIR/STTR RPGS
Novel Strategies to Enhance Drug Delivery and Tumor Immunogenicity in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2024 – 2027

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is a deadly form of pancreatic cancer with limited treatment options and a low overall survival rate. Oncolytic viruses, particular...

$13.77M
USD
Active NON-SBIR/STTR RPGS
Novel extremophile-inspired radioprotectants
NATIONAL CANCER INSTITUTE University of Iowa United States 2024 – 2027

Project Summary Over 60% of cancer patients undergo radiation therapy during their disease process, which frequently leads to injury to surrounding healthy tissue and results in co...

$13.54M
USD
Active NON-SBIR/STTR RPGS
Enhancing CAR T cell fitness using novel epigenetic reprogramming factors
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable clinical responses in patients with B cell malignancies. However, approximately...

$16.02M
USD
Active NON-SBIR/STTR RPGS
Expanding CAR T cell applications through high-throughput forward- and reverse immune engineering
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2027

Adaptive immunity is one of the most complex and clinically relevant aspects of human biology, where immune cells have evolved over millions of years to discriminate non-self from...

$15.26M
USD
Active NON-SBIR/STTR RPGS
A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2029

ABSTRACT The incidence of skin cancer has increased over the past several decades. Limiting exposure to ultraviolet radiation and engaging in early detection can reduce skin cancer...

$7.07M
USD
Active NON-SBIR/STTR RPGS
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2024 – 2029

PROJECT SUMMARY Tobacco use remains the leading preventable cause of death and illness in our society and causes 30% of cancer deaths. Despite this, 28.3 million US adults smoke. M...

$7.07M
USD
Active OTHER RESEARCH-RELATED
Georgia Science Education Initiative NCI YES (GA-YES)
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

Project Summary/Abstract While the racial and ethnic diversity of the US has increased over time, the diversity of those involved in cancer and biomedical research has not reflecte...

$3.13M
USD
Active OTHER RESEARCH-RELATED
Future Deaf Scientists Program at Wilmot Cancer Institute
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2029

PROJECT SUMMARY /ABSTRACT People with disabilities – especially deaf and hard-of-hearing individuals – continue to be underrepresented in STEM graduate programs, health science pro...

$2.56M
USD
Active NON-SBIR/STTR RPGS
Causes and consequences of genomic instability in myelodysplasia
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Myelodysplastic syndromes (MDS) are a group of age-related marrow failure disorders characterized by cytopenia and anemia. It is estimated that 10,000 new...

$5.85M
USD
Active NON-SBIR/STTR RPGS
Molecular mechanisms of developmental reprogramming in colorectal cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Colorectal cancer (CRC) is growing global threat, especially among younger adults. Impaired differentiation is a critical mechanism by which CRC cells unlock cell state plasticity;...

$5.52M
USD
Active NON-SBIR/STTR RPGS
Randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients: Increasing access in underserved rural communities
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Abstract People with advanced cancer experience a greater frequency and severity of physical and psychological symptoms, ranking sleep difficulties, worry-anxiety, depression, and...

$6.56M
USD